SCHEMBL7623945

SCHEMBL7623945

C1CCC(/N=C(/NC2CCCCC2)NC2CCNCC2)CC1

nearest known ligand 0.71

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 8/20 0.71
EPHX1 P07099 7/20 0.56
POLB P06746 1/20 0.40
CHRM5 P08912 1/20 0.39
CHRM3 P20309 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
KDM4E B2RXH2 1/20 0.38
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7623949 1.00 SIGMAR1 (0.71) SIGMAR1EPHX1POLBCHRM5CHRM3
SCHEMBL250080 0.88 SIGMAR1 (0.91) SIGMAR1EPHX1ALDH1A1CYP3A4NPC1
SCHEMBL20185673 0.82 SIGMAR1 (0.53) SIGMAR1EPHX1CHRM5CHRM3KDM4E
SCHEMBL20185674 0.82 SIGMAR1 (0.53) SIGMAR1EPHX1CHRM5CHRM3KDM4E
Piperazine SCHEMBL28204588 0.80 SIGMAR1 (0.54) SIGMAR1EPHX1CHRM5CHRM3ALDH1A1
SCHEMBL6155365 0.80 SIGMAR1 (0.76) SIGMAR1EPHX1ALDH1A1CYP3A4NPC1
SCHEMBL18230710 0.80 SIGMAR1 (0.50) SIGMAR1EPHX1CHRM5CHRM3
SCHEMBL18230709 0.80 SIGMAR1 (0.50) SIGMAR1EPHX1CHRM5CHRM3
SCHEMBL6154078 0.77 SIGMAR1 (0.70) SIGMAR1EPHX1ALDH1A1CYP3A4NPC1
SCHEMBL18740827 0.76 SIGMAR1 (0.68) SIGMAR1EPHX1ALDH1A1CYP3A4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455700-B1 THERAPY FOR NEUROKININ SENSITIVE DISEASE BOEHRINGER INGELHEIM PHARMA KG. (DE) 2002-09-24 US disclosed
EP-1086088-A2 NOVEL NEUROKININ ANTAGONISTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS Boehringer Ingelheim Pharma KG (DE) 2001-03-28 EP disclosed
WO-1999062893-A2 NOVEL NEUROKININ ANTAGONISTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-09 WO disclosed